Active, Not Recruiting
Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation
NCT02632708
- Conditions
- AML Arising After Exposure to Genotoxic Injury, AML Arising From Antecedent Hematologic Disorder (AHD), AML Arising From Myelodysplastic Syndrome (MDS), +9 more
- Locations
-
- City of Hope Duarte, California, United States
- UCLA Medical Center Los Angeles, California, United States
- University of Colorado Aurora, Colorado, United States
- University of Chicago Chicago, Illinois, United States